Traders Buy Shares of Walgreens Boots Alliance (WBA) on Weakness

Traders purchased shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on weakness during trading hours on Friday. $85.38 million flowed into the stock on the tick-up and $75.82 million flowed out of the stock on the tick-down, for a money net flow of $9.56 million into the stock. Of all stocks tracked, Walgreens Boots Alliance had the 22nd highest net in-flow for the day. Walgreens Boots Alliance traded down ($2.12) for the day and closed at $65.47

WBA has been the topic of several recent analyst reports. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Royal Bank of Canada set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, February 16th. SunTrust Banks set a $80.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Thursday, December 21st. Finally, ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $84.20.

How to Become a New Pot Stock Millionaire

The firm has a market capitalization of $64,924.38, a P/E ratio of 12.84, a price-to-earnings-growth ratio of 1.06 and a beta of 1.21. The company has a quick ratio of 0.47, a current ratio of 0.90 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the consensus estimate of $1.55 by $0.18. The company had revenue of $33.02 billion for the quarter, compared to the consensus estimate of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. Walgreens Boots Alliance’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period last year, the business posted $1.36 EPS. analysts forecast that Walgreens Boots Alliance Inc will post 5.93 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.44%. Walgreens Boots Alliance’s payout ratio is currently 31.37%.

In other news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 14.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in WBA. Arrowstreet Capital Limited Partnership boosted its position in Walgreens Boots Alliance by 675.5% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 5,891,845 shares of the pharmacy operator’s stock valued at $427,866,000 after acquiring an additional 5,132,140 shares in the last quarter. LSV Asset Management boosted its position in shares of Walgreens Boots Alliance by 38,624.0% in the 4th quarter. LSV Asset Management now owns 3,678,780 shares of the pharmacy operator’s stock worth $267,153,000 after purchasing an additional 3,669,280 shares in the last quarter. Two Sigma Advisers LP boosted its position in shares of Walgreens Boots Alliance by 315.6% in the 4th quarter. Two Sigma Advisers LP now owns 2,639,155 shares of the pharmacy operator’s stock worth $191,655,000 after purchasing an additional 2,004,131 shares in the last quarter. CI Global Investments Inc. boosted its position in shares of Walgreens Boots Alliance by 32.0% in the 4th quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock worth $535,470,000 after purchasing an additional 1,785,449 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. boosted its position in shares of Walgreens Boots Alliance by 875.2% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 1,650,553 shares of the pharmacy operator’s stock worth $119,862,000 after purchasing an additional 1,481,305 shares in the last quarter. 60.94% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Traders Buy Shares of Walgreens Boots Alliance (WBA) on Weakness” was originally reported by WKRB News and is the property of of WKRB News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.wkrb13.com/2018/04/01/traders-buy-shares-of-walgreens-boots-alliance-wba-on-weakness.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply